News

AmpliTech Group, Inc. (AMPG) Q4 2025 Earnings Call Transcript

1 Mins read

Operator

Good day, ladies and gentlemen, and welcome to AmpliTech Group’s Quarterly Investor Update Call, where the company will discuss its FY 2025 Financial Results. Present in this call, we have the executive team of AmpliTech Group, Fawad Maqbool, CEO, CTO and Board Chair; Jorge Flores, COO; and Louisa Sanfratello, CFO. [Operator Instructions]

As a reminder, today’s conference is being recorded. I would now like to turn the call over to AmpliTech’s COO, Jorge Flores.

Jorge Flores
Chief Operating Officer

Thank you, operator, and thank you, everyone, for joining today’s call to review the progress of AmpliTech’s growth initiatives and to answer investors’ questions. Following initial management comments, we will open the call to investors’ questions as well. An archived replay of today’s call will be posted to the Investor Relationship section of AmpliTech’s corporate website. This call is taking place on Thursday, April 9, 2026.

Remarks that follow and answers to questions may include statements that the company believes to be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally include words such as anticipate, believe, expect or words of similar importance. Likewise, statements that describe future plans, objectives or goals are also forward-looking. These forward-looking statements are subject to various risks that could cause actual results to be materially different than expected. Such risks include, among others, matters that the company has described in its press releases and in its filings with the Securities and Exchange Commission. Except as described in these filings, the company disclaims any obligation to

Read the full article here

Related posts
News

The Buckle, Inc. (BKE) Period Ending/ Trading Statement Call Prepared Remarks Transcript

1 Mins read
Adam AkersonVP of Finance, Controller & Assistant Treasurer This is Adam Akerson with Buckle, and this is a recording of Buckle’s commentary…
News

Ultragenyx Pharmaceutical: The Market Is Overlooking 2026 Catalysts (NASDAQ:RARE)

1 Mins read
This article was written by Follow Biologics is a full-time healthcare investor who developed a passion for biotech and life saving therapies…
News

AVIV: Should Keep Rising If The Ceasefire Holds (NYSEARCA:AVIV)

1 Mins read
This article was written by Follow With over three years of finance and consulting experience, Nikola is laser focused on finding value…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *